FR2498186A1 - Preparation de la chloro-5, -6, -7 ou -8 hydroxy-4 quinoleine - Google Patents
Preparation de la chloro-5, -6, -7 ou -8 hydroxy-4 quinoleine Download PDFInfo
- Publication number
- FR2498186A1 FR2498186A1 FR8100764A FR8100764A FR2498186A1 FR 2498186 A1 FR2498186 A1 FR 2498186A1 FR 8100764 A FR8100764 A FR 8100764A FR 8100764 A FR8100764 A FR 8100764A FR 2498186 A1 FR2498186 A1 FR 2498186A1
- Authority
- FR
- France
- Prior art keywords
- chloro
- hydroxy
- quinoline
- acid
- quinolinone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title abstract description 4
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 title description 10
- 239000003054 catalyst Substances 0.000 abstract description 15
- 238000000034 method Methods 0.000 abstract description 13
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 abstract description 13
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract description 11
- 239000001301 oxygen Substances 0.000 abstract description 11
- 229910052760 oxygen Inorganic materials 0.000 abstract description 11
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 abstract description 8
- 230000003197 catalytic effect Effects 0.000 abstract description 8
- 238000006356 dehydrogenation reaction Methods 0.000 abstract description 8
- 229910052707 ruthenium Inorganic materials 0.000 abstract description 7
- 229910052697 platinum Inorganic materials 0.000 abstract description 5
- XNMYNYSCEJBRPZ-UHFFFAOYSA-N 2-[(3-butyl-1-isoquinolinyl)oxy]-N,N-dimethylethanamine Chemical compound C1=CC=C2C(OCCN(C)C)=NC(CCCC)=CC2=C1 XNMYNYSCEJBRPZ-UHFFFAOYSA-N 0.000 abstract 1
- 229960005038 quinisocaine Drugs 0.000 abstract 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 238000006243 chemical reaction Methods 0.000 description 14
- HXEWMTXDBOQQKO-UHFFFAOYSA-N 4,7-dichloroquinoline Chemical compound ClC1=CC=NC2=CC(Cl)=CC=C21 HXEWMTXDBOQQKO-UHFFFAOYSA-N 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 239000007864 aqueous solution Substances 0.000 description 9
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
- 239000008346 aqueous phase Substances 0.000 description 8
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 8
- PBKONEOXTCPAFI-UHFFFAOYSA-N 1,2,4-trichlorobenzene Chemical compound ClC1=CC=C(Cl)C(Cl)=C1 PBKONEOXTCPAFI-UHFFFAOYSA-N 0.000 description 7
- 238000004817 gas chromatography Methods 0.000 description 7
- DUQIMDPEIHBKCJ-UHFFFAOYSA-N 7-chloro-3h-quinolin-4-one Chemical compound O=C1CC=NC2=CC(Cl)=CC=C21 DUQIMDPEIHBKCJ-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- -1 N- (4-chloro-4-quinolyl) anthranilic acid Chemical compound 0.000 description 6
- PMZDQRJGMBOQBF-UHFFFAOYSA-N quinolin-4-ol Chemical compound C1=CC=C2C(O)=CC=NC2=C1 PMZDQRJGMBOQBF-UHFFFAOYSA-N 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- XMFXTXKSWIDMER-UHFFFAOYSA-N 7-chloro-1h-quinolin-4-one Chemical compound ClC1=CC=C2C(O)=CC=NC2=C1 XMFXTXKSWIDMER-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000012074 organic phase Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 229910015900 BF3 Inorganic materials 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 4
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- 239000000956 alloy Substances 0.000 description 4
- 229910045601 alloy Inorganic materials 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- HOLTZTRNTRXTNX-UHFFFAOYSA-N 7-chloro-2,3-dihydro-1h-quinolin-4-one Chemical compound O=C1CCNC2=CC(Cl)=CC=C21 HOLTZTRNTRXTNX-UHFFFAOYSA-N 0.000 description 3
- PWJXTAIEMDMKPF-UHFFFAOYSA-N 7-chloro-6H-quinolin-7-ol Chemical compound ClC1(CC=C2C=CC=NC2=C1)O PWJXTAIEMDMKPF-UHFFFAOYSA-N 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 238000010908 decantation Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- BUWPZNOVIHAWHW-UHFFFAOYSA-N 2,3-dihydro-1h-quinolin-4-one Chemical compound C1=CC=C2C(=O)CCNC2=C1 BUWPZNOVIHAWHW-UHFFFAOYSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- WIXUZVQMOUIMNP-UHFFFAOYSA-N 2-(3-chloroanilino)propanoic acid Chemical compound OC(=O)C(C)NC1=CC=CC(Cl)=C1 WIXUZVQMOUIMNP-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- KNDOFJFSHZCKGT-UHFFFAOYSA-N 4-chloroquinoline Chemical compound C1=CC=C2C(Cl)=CC=NC2=C1 KNDOFJFSHZCKGT-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- GWOFUCIGLDBNKM-UHFFFAOYSA-N glafenine Chemical compound OCC(O)COC(=O)C1=CC=CC=C1NC1=CC=NC2=CC(Cl)=CC=C12 GWOFUCIGLDBNKM-UHFFFAOYSA-N 0.000 description 2
- 229960001650 glafenine Drugs 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- NDJKXXJCMXVBJW-UHFFFAOYSA-N heptadecane Chemical compound CCCCCCCCCCCCCCCCC NDJKXXJCMXVBJW-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- KUDPGZONDFORKU-UHFFFAOYSA-N n-chloroaniline Chemical compound ClNC1=CC=CC=C1 KUDPGZONDFORKU-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 description 2
- 229930185107 quinolinone Natural products 0.000 description 2
- 239000003507 refrigerant Substances 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- CVICEEPAFUYBJG-UHFFFAOYSA-N 5-chloro-2,2-difluoro-1,3-benzodioxole Chemical group C1=C(Cl)C=C2OC(F)(F)OC2=C1 CVICEEPAFUYBJG-UHFFFAOYSA-N 0.000 description 1
- SDRJFDTZVULXDE-UHFFFAOYSA-N 7-chloro-1h-quinolin-2-one Chemical compound C1=CC(Cl)=CC2=NC(O)=CC=C21 SDRJFDTZVULXDE-UHFFFAOYSA-N 0.000 description 1
- QNGUPQRODVPRDC-UHFFFAOYSA-N 7-chloroquinoline Chemical compound C1=CC=NC2=CC(Cl)=CC=C21 QNGUPQRODVPRDC-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 239000012300 argon atmosphere Substances 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 229960003677 chloroquine Drugs 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 238000005695 dehalogenation reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000007792 gaseous phase Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- ZEXKKIXCRDTKBF-UHFFFAOYSA-N quinoline-2-carboxamide Chemical compound C1=CC=CC2=NC(C(=O)N)=CC=C21 ZEXKKIXCRDTKBF-UHFFFAOYSA-N 0.000 description 1
- PCQHXVJZEJOUHL-UHFFFAOYSA-N quinoline;1h-quinolin-2-one Chemical compound N1=CC=CC2=CC=CC=C21.C1=CC=C2NC(=O)C=CC2=C1 PCQHXVJZEJOUHL-UHFFFAOYSA-N 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- FNXKBSAUKFCXIK-UHFFFAOYSA-M sodium;hydrogen carbonate;8-hydroxy-7-iodoquinoline-5-sulfonic acid Chemical class [Na+].OC([O-])=O.C1=CN=C2C(O)=C(I)C=C(S(O)(=O)=O)C2=C1 FNXKBSAUKFCXIK-UHFFFAOYSA-M 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Quinoline Compounds (AREA)
- Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Priority Applications (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8100764A FR2498186A1 (fr) | 1981-01-16 | 1981-01-16 | Preparation de la chloro-5, -6, -7 ou -8 hydroxy-4 quinoleine |
| JP57003536A JPS57171970A (en) | 1981-01-16 | 1982-01-14 | Manufacture of 4-hydroxyquinolines |
| IN35/DEL/82A IN158326B (enExample) | 1981-01-16 | 1982-01-15 | |
| AT82400079T ATE13881T1 (de) | 1981-01-16 | 1982-01-15 | Herstellung von 4-hydroxychinolinen. |
| ZA82278A ZA82278B (en) | 1981-01-16 | 1982-01-15 | Preparation of 4-hydroxyquinolines |
| DE8282400079T DE3264152D1 (en) | 1981-01-16 | 1982-01-15 | Preparation of 4-hydroxyquinolines |
| EP82400079A EP0056765B1 (fr) | 1981-01-16 | 1982-01-15 | Préparation d'hydroxy-4 quinoléines |
| KR8200162A KR870001897B1 (ko) | 1981-01-16 | 1982-01-15 | 4-하이드록시키놀린의 제조방법 |
| IE76/82A IE51958B1 (en) | 1981-01-16 | 1982-01-15 | Preparation of 4-hydroxyquinolines |
| DK17382A DK149450C (da) | 1981-01-16 | 1982-01-15 | Fremgangsmaade til fremstilling af 4-hydroxyquinoliner |
| HU82120A HU184984B (en) | 1981-01-16 | 1982-01-15 | Process for producing 4-hydroxy-quinolines |
| CA000394261A CA1181072A (fr) | 1981-01-16 | 1982-01-15 | Preparation d'hydroxy-4-quinoleines |
| US06/339,723 US4412076A (en) | 1981-01-16 | 1982-01-15 | Preparation of 4-hydroxyquinolines |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8100764A FR2498186A1 (fr) | 1981-01-16 | 1981-01-16 | Preparation de la chloro-5, -6, -7 ou -8 hydroxy-4 quinoleine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2498186A1 true FR2498186A1 (fr) | 1982-07-23 |
| FR2498186B1 FR2498186B1 (enExample) | 1983-10-28 |
Family
ID=9254222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR8100764A Granted FR2498186A1 (fr) | 1981-01-16 | 1981-01-16 | Preparation de la chloro-5, -6, -7 ou -8 hydroxy-4 quinoleine |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4412076A (enExample) |
| EP (1) | EP0056765B1 (enExample) |
| JP (1) | JPS57171970A (enExample) |
| KR (1) | KR870001897B1 (enExample) |
| AT (1) | ATE13881T1 (enExample) |
| CA (1) | CA1181072A (enExample) |
| DE (1) | DE3264152D1 (enExample) |
| DK (1) | DK149450C (enExample) |
| FR (1) | FR2498186A1 (enExample) |
| HU (1) | HU184984B (enExample) |
| IE (1) | IE51958B1 (enExample) |
| IN (1) | IN158326B (enExample) |
| ZA (1) | ZA82278B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2528836A1 (fr) * | 1982-06-17 | 1983-12-23 | Rhone Poulenc Sante | Procede de preparation d'hydroxy-4 quinoleines |
| MX13484A (es) * | 1987-10-19 | 1993-05-01 | Pfizer | Procedimiento para la obtencion de tetralinas, cromanos y compuestos relacionados, sustituidos |
| US6166031A (en) * | 1987-10-19 | 2000-12-26 | Pfizer Inc, | Substituted tetralins, chromans and related compounds in the treatment of asthma |
| DE69528160T2 (de) * | 1994-03-01 | 2003-02-06 | Chemipro Kasei Kaisha, Ltd. | Verfahren zur herstellung von 5,7 dichlor-4-hydroxychinolin |
| CN116588893B (zh) * | 2023-06-08 | 2025-11-11 | 中国科学院宁波材料技术与工程研究所 | 储氢材料、储氢组合物及应用、氢气存储及脱附方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2558211A (en) * | 1949-04-14 | 1951-06-26 | Lilly Co Eli | Preparation of 4-hydroxyquinoline compounds |
-
1981
- 1981-01-16 FR FR8100764A patent/FR2498186A1/fr active Granted
-
1982
- 1982-01-14 JP JP57003536A patent/JPS57171970A/ja active Granted
- 1982-01-15 AT AT82400079T patent/ATE13881T1/de active
- 1982-01-15 ZA ZA82278A patent/ZA82278B/xx unknown
- 1982-01-15 US US06/339,723 patent/US4412076A/en not_active Expired - Fee Related
- 1982-01-15 DE DE8282400079T patent/DE3264152D1/de not_active Expired
- 1982-01-15 CA CA000394261A patent/CA1181072A/fr not_active Expired
- 1982-01-15 KR KR8200162A patent/KR870001897B1/ko not_active Expired
- 1982-01-15 EP EP82400079A patent/EP0056765B1/fr not_active Expired
- 1982-01-15 IE IE76/82A patent/IE51958B1/en unknown
- 1982-01-15 DK DK17382A patent/DK149450C/da not_active IP Right Cessation
- 1982-01-15 IN IN35/DEL/82A patent/IN158326B/en unknown
- 1982-01-15 HU HU82120A patent/HU184984B/hu not_active IP Right Cessation
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2558211A (en) * | 1949-04-14 | 1951-06-26 | Lilly Co Eli | Preparation of 4-hydroxyquinoline compounds |
Non-Patent Citations (1)
| Title |
|---|
| EXBK/52 * |
Also Published As
| Publication number | Publication date |
|---|---|
| HU184984B (en) | 1984-11-28 |
| US4412076A (en) | 1983-10-25 |
| DK149450C (da) | 1986-11-24 |
| KR870001897B1 (ko) | 1987-10-21 |
| DK149450B (da) | 1986-06-16 |
| KR830009033A (ko) | 1983-12-17 |
| JPH0249305B2 (enExample) | 1990-10-29 |
| DE3264152D1 (en) | 1985-07-25 |
| FR2498186B1 (enExample) | 1983-10-28 |
| EP0056765A1 (fr) | 1982-07-28 |
| JPS57171970A (en) | 1982-10-22 |
| ATE13881T1 (de) | 1985-07-15 |
| IE820076L (en) | 1982-07-16 |
| EP0056765B1 (fr) | 1985-06-19 |
| CA1181072A (fr) | 1985-01-15 |
| IN158326B (enExample) | 1986-10-18 |
| IE51958B1 (en) | 1987-04-29 |
| DK17382A (da) | 1982-07-17 |
| ZA82278B (en) | 1982-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0056766B1 (fr) | Procédé de préparation d'amino-4 chloroquinoléines | |
| EP0719764B1 (fr) | Dérivés de 3-phénylisoquinoléin-1(2H)-one comme ligands des récepteurs benzodiazépiniques associés aux récepteurs GABAA | |
| EP0139584B1 (fr) | Dérivés d'imidazoline, leur préparation et leur application en thérapeutique | |
| CA1097647A (fr) | Procede de preparation de nouvelles imidazoquinoleines et de leurs sels | |
| FR2498186A1 (fr) | Preparation de la chloro-5, -6, -7 ou -8 hydroxy-4 quinoleine | |
| EP0056763B1 (fr) | Procédé de préparation de quinolinones-4 | |
| BE854655A (fr) | 9-hydroxyhexahydrobenzo (c) quinoleines et intermediaires de synthese | |
| FR2476079A1 (fr) | Nouveaux derives tetrahydroquinaldiniques, leur procede de preparation et leur utilisation dans la production de flumequine | |
| EP0097585B1 (fr) | Procédé de préparation d'hydroxy-4 quinoleines | |
| EP0177398B1 (fr) | Dérivés chlores de l'hexadécène, leur préparation et leur emploi dans la synthèse de la vitamine e | |
| JPH01186838A (ja) | ３−（４’−ブロモビフェニル）−４−フェニル酪酸の製造方法 | |
| EP0035925A1 (fr) | Nouveaux dérivés de la chloro-3 quinoléine, procédés pour leur préparation, et médicaments les contenant | |
| EP0143018B1 (fr) | Procédé de préparation de quinolinones-4 | |
| EP0140748B1 (fr) | Procédé de préparation de quinolinones-4 | |
| FR2750427A1 (fr) | Derives de 1-oxo-1, 2-dihydroisoquinoleine-4-propanamide, leur preparation et leur application en therapeutique | |
| EP0311467B1 (fr) | Utilisation de dérivés de pyrrolo[3,2,1-hi]indole pour obtenir un médicament destiné au traitement du diabète | |
| EP0145591A2 (fr) | Dérivés de pyrrolo[3,2,1-hi]indole, leur préparation et leur application en thérapeutique | |
| CZ74097A3 (en) | Process for preparing r-(+)-1,2,3,6-tetrahydro-4-phenyl-1-£(3-phenyl-3-cyclohexen-1-yl)methyl|py- ridine, intermediates for such process and process for preparing the intermediates | |
| Hager et al. | Synthetic Analogs of the Adrenal Cortical Hormones. II. Synthesis of 4, 4′-bis (acetoxyacetyl)-α, α′-diethylstilbene | |
| FR2553416A1 (fr) | Derive de pyrrolo-quinoline, sa preparation et son application en therapeutique | |
| FR2536400A1 (fr) | 3-(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxopurine-7-acetyl)-8-(2-phenylethyl)-1-oxa-3,8-diazaspiro (4,5) decane-2-one, utile comme bronchodilatateur ou anti-inflammatoire, et son procede de preparation | |
| FR2556345A1 (fr) | Derive de pyrrolo(3,2,1-hi) indole, sa preparatio n et son application en therapeutique | |
| FR2559485A2 (fr) | Derives de pyrrolo-quinoline, leur preparation et leur application en therapeutique | |
| FR2565230A1 (fr) | Derives de (1h-dihydro-4,5 imidazolyl-2)-2 hexahydro-1,2,4,5,6,7 azepino (3,2,1-hi) indole, leur preparation et leur application en therapeutique | |
| EP0056764A1 (fr) | Procédé de préparation de la chloro-7 tétrahydro-1,2,3,4 quinolinone-4 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |